产品封面图
文献支持

Daudi、Daudi、Daudi细胞、Daudi细胞、Da

udi Burkitt淋巴瘤细胞
收藏
  • ¥1400
  • EK-Bioscience已认证
  • 国内
  • SY4361
  • 2025年07月14日
    avatar
    品牌商
    12钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 英文名

      Daudi

    • 库存

      1x10^6/瓶

    • 供应商

      上海酶研

    • 肿瘤类型

      Burkitt淋巴瘤

    • 细胞类型

      Daudi

    • 品系

      Daudi

    • 组织来源

      人Burkitt淋巴瘤细胞

    • 相关疾病

      详询

    • 物种来源

    • 免疫类型

      详询

    • 细胞形态

      贴壁/悬浮

    • 是否是肿瘤细胞

    • 器官来源

      人Burkitt淋巴瘤细胞

    • 运输方式

      顺丰快递

    • 年限

      5年

    • 生长状态

      生长良好

    • 规格

    Daudi、Daudi、Daudi细胞、Daudi细胞、Daudi人Burkitt淋巴瘤细胞

    Cell line name Daudi

    Synonyms DAUDI; NK-10A; NK-10a; NK 10a; NK10a; N; GM03190; GM3190; GM03190A; GM17346

    Accession CVCL_0008

    Resource Identification Initiative To cite this cell line use: Daudi (RRID:CVCL_0008)

    Comments Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

    Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: Human variation panel.

    Part of: LL-100 blood cancer cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Population: African; Kenyan.

    Doubling time: 23.7 hours (PubMed=8847894); ~48 hours (DSMZ=ACC-78).

    Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).

    Microsatellite instability: Instable (MSI-low) (Sanger).

    Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

    Omics: Deep antibody staining analysis.

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Omics: Virome analysis using RNAseq.

    Caution: TP53 mutation indicated incorrectly as being at c.637C>T in PubMed=2052620.

    Misspelling: Duadi; Note=Occasionally.

    Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

    Cell type: B-cell; CL=CL_0000236.

    PubMed=7316467; DOI=10.1111/j.1469-1809.1980.tb00953.x

    Povey S., Jeremiah S., Arthur E., Steel M., Klein G.

    Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy.

    Ann. Hum. Genet. 44:119-133(1980)

     

    PubMed=6935474; DOI=10.1093/jnci/66.2.239

    Wright W.C., Daniels W.P., Fogh J.

    Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.

    J. Natl. Cancer Inst. 66:239-247(1981)

     

    PubMed=6286763; DOI=10.4049/jimmunol.129.3.1336

    Benjamin D., Magrath I.T., Maguire R.T., Janus C., Todd-Kulikowsk H.D., Parsons R.G.

    Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and non-Burkitt's type.

    J. Immunol. 129:1336-1342(1982)

     

    PubMed=6806672; DOI=10.1038/298474a0

    Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R.

    Correlation between immunoglobulin light chain expression and variant translocation in Burkitt's lymphoma.

    Nature 298:474-476(1982)

     

    PubMed=6954533; DOI=10.1073/pnas.79.7.2194; PMCID=PMC346157

    Westin E.H., Gallo R.C., Arya S.K., Eva A., Souza L.M., Baluda M.A., Aaronson S.A., Wong-Staal F.

    Differential expression of the amv gene in human hematopoietic cells.

    Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982)

     

    PubMed=6186604; DOI=10.1007/BF00364753

    de Preval C., Mach B.

    The absence of beta 2-microglobulin in Daudi cells: active gene but inactive messenger RNA.

    Immunogenetics 17:133-140(1983)

     

    PubMed=11894933; DOI=10.1002/j.1460-2075.1983.tb01412.x; PMCID=PMC555120

    Rosa F.M., Berissi H., Weissenbach J., Maroteaux L., Fellous M., Revel M.

    The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon.

    EMBO J. 2:239-243(1983)

     

    PubMed=6200433; DOI=10.1007/BF00364762

    Brodsky F.M.

    A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.

    Immunogenetics 19:179-194(1984)

     

    PubMed=6231253; DOI=10.1002/ijc.2910330407

    Ehlin-Henriksson B., Klein G.

    Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation.

    Int. J. Cancer 33:459-463(1984)

     

    PubMed=6500159; DOI=10.1159/000163283

    Gershwin M.E., Lentz D., Owens R.B.

    Relationship between karyotype of tissue culture lines and tumorigenicity in nude mice.

    Exp. Cell Biol. 52:361-370(1984)

     

    PubMed=6547209; DOI=10.1038/309592a0

    Rabbitts T.H., Forster A., Hamlyn P.H., Baer R.

    Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.

    Nature 309:592-597(1984)

     

    PubMed=6582512; DOI=10.1073/pnas.81.2.568; PMCID=PMC344720

    Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.

    Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.

    Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984)

     

    PubMed=6592381; DOI=10.1093/jnci/73.4.841

    Favrot M.-C., Philip I., Philip T., Portoukalian J., Dore J.-F., Lenoir G.M.

    Distinct reactivity of Burkitt's lymphoma cell lines with eight monoclonal antibodies correlated with the ethnic origin.

    J. Natl. Cancer Inst. 73:841-847(1984)

     

    PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0

    Drexler H.G., Gaedicke G., Minowada J.

    Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 carboxylic esterase.

    Leuk. Res. 9:209-229(1985)

     

    PubMed=2998993

    Steel C.M., Morten J.E.N., Foster E.

    The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.

    IARC Sci. Publ. 60:265-292(1985)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    相关实验
    • 抑制B淋巴细胞瘤生长的嵌合抗CD20基因工程抗体

      、14.6μg/ml)低于Fab’对Raji、Daudi的IC50(45.9μg/ml、39.5μg/ml)。Fab'(50mg/kg,i.v.)和F(ab’)2(50mg/kg,i.p.)对荷瘤鼠瘤块体积的增长有抑制作用。结论 实现了直接在大肠杆菌中高效可溶性分泌表达有活性的抗CD20嵌合抗体Fab’和F(ab’)2的目的。Fab’适于显象,F(ab)2片段的抑制肿瘤生长活性明显高于Fab’,半衰期长于Fab’,更适于治疗。【关键词】B淋巴细胞瘤嵌合抗体Fab’片段 嵌合抗体F(ab)2片段CD20B淋巴细胞

    • LAK细胞和TIL活性的测定

      LAK细胞和TIL活性的测定基本同NK活性测定方法。但所用靶细胞为对NK不敏感的肿瘤细胞,如Raji、Daudi或自体肿瘤细胞。常采用同位素法如51 Cr释放试验、发光免疫测定法及MTT比色法等。 在此介绍MTT比色法。 试剂及材料 1. 试剂:①四甲基偶氮盐(MTT);②酸化异丙醇:含0.04mol/L HCl的异丙醇;③96孔细胞培养板。 2. 肿瘤细胞系: Raji细胞Daudi细胞为B细胞性白血病细胞株;Molt-4为T细胞性白血病细胞,对LAK细胞敏感

    • Construction of RibonucleaseAntibody Conjugates for Selective Cytotoxicity

      -resistant colon cancer cells in vitro and in vivo (7 ). Recently, RNase chemically conjugated to an antibody against CD22 was found to specifically kill Daudi lymphoma cells in cell culture at picomolar concentrations (IC50 , 10-50 pM) and to exhibit potent

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1480
    上海酶研生物科技有限公司
    2025年12月31日询价
    ¥900
    上海泽叶生物科技有限公司
    2025年12月31日询价
    询价
    上海沪震实业有限公司
    2025年12月29日询价
    ¥1680
    吉奥蓝图(广东)生命科学技术中心
    2025年09月19日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月07日询价
    文献支持
    Daudi、Daudi、Daudi细胞、Daudi细胞、Daudi Burkitt淋巴瘤细胞
    ¥1400